Susan Brown2019-08-222019-08-222002-05-012014-03-31https://hdl.handle.net/20.500.12503/29180Ratliff, Marla D., Impact of Intraocular Pressure Maintenance on Sight Preservation. Master of Public Health (Health Services Research), May 2002, 35 pp., 3 tables, 1 figure, 40 titles. Purpose: The objective of the study was to review diurnal IOP control and its impact on sight preservation. Methods: This is a retrospective study used in patients with elevated IOP. Patient IOPs were measured every 4 hours over a 24-hour period. Qualified patients provided open label TRAVATAN to dose once a day for 2 weeks. Following 2 weeks of dosing, IOP measurements were taken every 4 hours for 36 hours. Additional IOP measurements were taken at 60 and 84 hours after the last dose of TRAVATAN. Results: The IOP changes from baseline were statistically significant (p≤0.0001) at all time points out to 36 hours. Even without additional dosing, substantial IOP reductions (6mm Hg) were maintained out to 84 hours. Conclusions: Use of TRAVATAN may have less impact on IOP maintenance due to non-compliance and missed doses. This could help prevent glaucomatous loss and preserve sight.application/pdfenEye DiseasesLife SciencesMedicine and Health SciencesOphthalmologyOptometryPharmacy and Pharmaceutical SciencesSense OrgansVision ScienceIntraocular pressuremaintenancesight preservationdiurnal IOP controlTRAVATANglaucomatous lossnon-compliancemissed dosesThesis